Fundraising Fox
🦊/Companies
Sign in

Tactiva Therapeutics

Chicago, US · 3 known investors

Find your way into Tactiva Therapeutics

Tactiva Therapeutics develops immuno-oncology treatments using adoptive cell therapy approaches for cancer patients. The company leverages innovative methods in T cell engineering and gene therapy to address metastatic and gynecological cancers.

BiotechHealthtechMedical Devices

Founders & leadership

RC
Richard C. KoyaCo-Founder
KO
Kunle OdunsiCo-Founder
JZ
Jay ZhangCEO

Investors · 3

Panacea VentureSingapore
EFung CapitalreportedShenzhen
VI PartnersreportedAltendorf · $2.2M – $4.5M

In the news

Tactiva takes $35m series A on board -globalventuring.com · Dec 2018Tactiva Therapeutics raises $35 million in venture capital; plans to create 45 jobs in Buffalo | Invest Buffalo Niagarabuffaloniagara.org · Dec 2018Tactiva Therapeutics Secures $35M in Series A Financing - FinSMEsfinsmes.com · Dec 2018Tactiva Therapeutics Secures $35 Million Series A Financing to Pursue Clinical Development of DEACT Platformprnewswire.com · Dec 2018Tactiva Therapeutics 12/4/2018 Capital Raise - Gaebler.com Venture Capital Databasegaebler.com

Frequently asked questions

What does Tactiva Therapeutics do?
Tactiva Therapeutics develops immuno-oncology treatments using adoptive cell therapy approaches for cancer patients. The company leverages innovative methods in T cell engineering and gene therapy to address metastatic and gynecological cancers.
Who founded Tactiva Therapeutics?
Tactiva Therapeutics was founded by Richard C. Koya, Kunle Odunsi.
Who are Tactiva Therapeutics's investors?
Tactiva Therapeutics's investors include Panacea Venture, EFung Capital, VI Partners.
Where is Tactiva Therapeutics headquartered?
Tactiva Therapeutics is headquartered in Chicago, US.